CARDOZA GEORGE sold $8K of SOPH
CARDOZA GEORGE (Chief Financial Officer) sold 1,592 shares of SOPHiA GENETICS SA (SOPH) at $5.29 on 2026-07-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity but does not include any new guidance, deal, regulatory action, or operational milestone.
Market read
Traders may monitor insider activity for sentiment, but the 10b5-1 framing reduces the signal strength.
What to watch
Insider sales can be offset by other insider buys or by the fact that the sale size is small relative to typical institutional float; the filing provides no new business information.
Background
The article is a primary-source SEC Form 4 insider transaction for SOPHiA GENETICS, reported by its CFO.
Ticker impact
SOPHiA GENETICS CFO CARDOZA GEORGE filed a Form 4 open-market sale of 1,592 shares at $5.2886 on 2026-07-06.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider activity.
The filing is a routine Form 4 transaction, explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying company-specific operational or guidance change.
Market effects
No clear sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish expectations.
Key entities
- issuerSOPHiA GENETICS SA
Subject of the Form 4 insider transaction; CFO sold shares via an open-market transaction under a 10b5-1 plan.
- insiderCARDOZA GEORGE
Chief Financial Officer who reported the sale of 1,592 shares.
